D. E. Shaw & Co., Inc. Revance Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,932,205 shares of RVNC stock, worth $4.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,932,205

Holding current value

$4.97 Million

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.57 - $2.57 $4.69 Million - $4.69 Million	1,824,225 Added 1689.41%	1,932,205 $4.97 Million
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $444,904 - $899,314	-190,130 Reduced 63.78%	107,980 $277,000
Q1 2024 May 15, 2024	SELL	$4.65 - $9.31 $528,426 - $1.06 Million	-113,640 Reduced 27.6%	298,110 $1.47 Million
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $2.15 Million - $4.15 Million	-370,266 Reduced 47.35%	411,750 $3.62 Million
Q3 2023 Nov 14, 2023	SELL	$11.47 - $25.07 $14.1 Million - $30.8 Million	-1,229,653 Reduced 61.13%	782,016 $8.97 Million
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $6.92 Million - $10.5 Million	-280,242 Reduced 12.23%	2,011,669 $50.9 Million
Q1 2023 May 15, 2023	BUY	$18.36 - $35.27 $17.5 Million - $33.6 Million	952,991 Added 71.18%	2,291,911 $73.8 Million
Q4 2022 Feb 14, 2023	SELL	$18.32 - $30.66 $2.39 Million - $4.01 Million	-130,653 Reduced 8.89%	1,338,920 $24.7 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $9.34 Million - $18.6 Million	651,833 Added 79.71%	1,469,573 $39.7 Million
Q2 2022 Aug 15, 2022	SELL	$11.52 - $20.4 $328,642 - $581,971	-28,528 Reduced 3.37%	817,740 $11.3 Million
Q1 2022 May 16, 2022	BUY	$12.36 - $20.31 $3.98 Million - $6.55 Million	322,350 Added 61.53%	846,268 $16.5 Million
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $6.41 Million - $14.3 Million	514,678 Added 5570.11%	523,918 $8.55 Million
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $1 Million - $1.29 Million	-38,847 Reduced 80.78%	9,240 $257,000
Q2 2021 Aug 16, 2021	BUY	$26.8 - $31.84 $1.29 Million - $1.53 Million	48,087 New	48,087 $1.43 Million
Q1 2021 May 17, 2021	SELL	$24.03 - $29.97 $214,659 - $267,722	-8,933 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.41 - $28.34 $530,259 - $641,929	-22,651 Reduced 71.72%	8,933 $253,000
Q3 2020 Nov 16, 2020	BUY	$23.23 - $34.3 $475,587 - $702,223	20,473 Added 184.26%	31,584 $794,000
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $14,981 - $31,567	-1,189 Reduced 9.67%	11,111 $271,000
Q1 2020 May 15, 2020	BUY	$12.46 - $27.81 $153,258 - $342,063	12,300 New	12,300 $182,000
Q3 2019 Nov 14, 2019	SELL	$10.22 - $14.5 $221,630 - $314,447	-21,686 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.67 - $15.49 $85,818 - $124,586	-8,043 Reduced 27.05%	21,686 $281,000
Q1 2019 May 15, 2019	SELL	$15.4 - $20.39 $1.09 Million - $1.44 Million	-70,761 Reduced 70.42%	29,729 $469,000
Q4 2018 Feb 14, 2019	BUY	$18.06 - $24.96 $637,301 - $880,788	35,288 Added 54.12%	100,490 $2.02 Million
Q3 2018 Nov 14, 2018	SELL	$23.55 - $30.1 $301,251 - $385,039	-12,792 Reduced 16.4%	65,202 $1.62 Million
Q2 2018 Aug 14, 2018	BUY	$27.45 - $33.35 $1.89 Million - $2.29 Million	68,706 Added 739.73%	77,994 $2.14 Million
Q1 2018 May 15, 2018	SELL	$29.15 - $37.4 $1.02 Million - $1.3 Million	-34,884 Reduced 78.97%	9,288 $286,000
Q4 2017 Feb 14, 2018	BUY	$24.55 - $36.3 $1.08 Million - $1.6 Million	44,172	44,172 $1.58 Million

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account